Romosozumab Active Not Recruiting Phase 4 Trials for Postmenopausal Osteoporosis Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT05010590Anabolic Therapy in Postmenopausal Osteoporosis